首页> 美国卫生研究院文献>BMC Proceedings >Does pathway analysis make it easier for common variants to tag rare ones?
【2h】

Does pathway analysis make it easier for common variants to tag rare ones?

机译:途径分析是否使普通变体更容易标记稀有基因?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Analyzing sequencing data is difficult because of the low frequency of rare variants, which may result in low power to detect associations. We consider pathway analysis to detect multiple common and rare variants jointly and to investigate whether analysis at the pathway level provides an alternative strategy for identifying susceptibility genes. Available pathway analysis methods for data from genome-wide association studies might not be efficient because these methods are designed to detect common variants. Here, we investigate the performance of several existing pathway analysis methods for sequencing data. In particular, we consider the global test, which does not consider linkage disequilibrium between the variants in a gene. We improve the performance of the global test by assigning larger weights to rare variants, as proposed in the weighted-sum approach. Our conclusion is that straightforward application of pathway analysis is not satisfactory; hence, when common and rare variants are jointly analyzed, larger weights should be assigned to rare variants.
机译:由于稀有变异的频率较低,因此难以分析测序数据,这可能导致检测关联的能力较低。我们考虑通过途径分析来共同检测多个常见和稀有变异体,并调查在途径水平上的分析是否提供了识别易感基因的替代策略。用于全基因组关联研究的数据的可用途径分析方法可能无效,因为这些方法旨在检测常见变体。在这里,我们研究了几种现有的测序数据途径分析方法的性能。特别是,我们考虑了全局检验,该检验不考虑基因变异之间的连锁不平衡。如加权和方法中所建议的,我们通过为稀有变量分配更大的权重来提高全局测试的性能。我们的结论是,直接应用途径分析并不令人满意。因此,当共同分析常见变体和稀有变体时,应将较大的权重分配给稀有变体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号